In vitro diagnostic tests are extremely useful to healthcare
- screening for diseases,
- referrals and follow-up treatment.
Between 60% and 70% of medical decisions are based upon in vitro diagnostic tests
The increasing importance of diagnostics
In vitro diagnostics contribute to medical decision-making.
Initially used to identify diseases, in vitro diagnostic tools are increasingly being used to:
- personalize patient management,
- indicate the most appropriate treatment,
- reduce side effects as much as possible,
- reduce healthcare spending.
In vitro diagnostics account for only 2% to 3% of healthcare spending
bioMérieux's product offering
- With 50 years of experience in the field of in vitro diagnostics, bioMérieux has contributed to the technological transformations in the field, enabling us to offer a range of increasingly sophisticated tools.
- Our solutions are primarily intended for the diagnosis of infectious diseases and cardiovascular emergencies, as well as screening and monitoring of cancers. We also offer diagnostic tests for metabolic, allergy-related and hormonal pathologies.
- Infections (urinary tract infections, septicemia): detection and identification of the bacterium responsible and selection of appropriate antibiotic treatment.
- Heathcare-associated (nosocomial) infections: detection and monitoring.
- Viral infections such as HIV, hepatitis, rubella, infectious mononucleosis, etc.: diagnosis and monitoring.
High medical-value tests
- Heart attack: the diagnostic test detects cardiac markers, indicating the destruction of myocardial cells.
- Venous thrombosis (phlebitis in one of the lower limbs, which can develop and become a pulmonary embolism): biological diagnostic tests detect substances (metabolites) released when the clot is formed.
Screening and monitoring tests
- A cancer is a proliferation of abnormal cells. Such cells carry unusual antigens on their surface or release abnormal substances into the blood: these are known as tumor markers.
- Detecting and quantifying these tumor markers form part of the screening and monitoring process for many cancers.